Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 750 de 1158 resultados encontrados
Opções avançadas
Data de publicação: 10/07/2020 - 12:50
A study by researchers of the CoVida Network - Science, Information and Solildarity showed that the measures to contain Covid-19 in Brazil have already saved millions of lives, but they are not enough to slow down the spread of the pandemic in Brazil. According to mathematical analysis, even in the states that were stricter in terms of social distancing measures since the beginning of the transmission of the country, this set of actions is still...
Notícias
Data de publicação: 09/07/2020 - 13:41
The Oswaldo Cruz Foundation (Fiocruz) and Convention Secretariat, which serves as the secretariat of both the WHO Framework Convention on Tobacco Control (WHO FCTC) and of the Protocol to Eliminate Illicit Trade in Tobacco Products, entered into a Memorandum of Understanding this Thursday (09 July). The document designates Fiocruz, through its Center for Tobacco and Health Studies (CETAB) of the National School of Public Health Sergio Arouca (...
Notícias
Data de publicação: 30/06/2020 - 17:59
The Oswaldo Cruz Foundation (Fiocruz) will sign an agreement with pharmaceutical company AstraZeneca for the acquisition of batches and transference of technology regarding the Covid-19 vaccine developed by the University of Oxford. The agreement will be the result of the cooperation between the Brazilian government and the pharmaceutic company, announced last Saturday, June 27, by the Ministry of Health. This is a Advance Purchase Agreement...
Notícias
Data de publicação: 29/06/2020 - 16:04
A study led by the Oswaldo Cruz Foundation (Fiocruz) has observed that drugs currently used to treat hepatitis C inhibit the replication of the new coronavirus (SARS-CoV-2) in experiments made with cells. The experiments have identified, in particular, the potential of an antiviral drug, daclastavir, which was able to work against the virus in three different cell lineages under investigation, in addition to reducing the production of...
Notícias
Data de publicação: 29/06/2020 - 15:14
Although respiratory symptoms are the best-known face of Covid-19, post-traumatic stress (PTSD), depression, and anxiety have also been described in patients with the disease. In an article published in Frontiers in Immunology, researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) and of Universidade Federal Fluminense (UFF), in the state of Rio de Janeiro, discuss how the new coronavirus can affect mental health, pointing to neural,...
Notícias
Data de publicação: 26/06/2020 - 18:05
Even in the midst of a pandemic that has affected the everyday life of virtually everyone, Brazilians are still living with the consequences of the last national public health emergency: the zika virus, which has led to the birth of 3,534 babies with congenital zika syndrome (CZS) since 2015. A new strain of the zika virus was recently discovered in Brazil by researchers of the Center for the Integration of Data and Knowledge for Health (Cidacs...
Notícias
Data de publicação: 26/06/2020 - 13:53
The Chagas Consortium of the Oswaldo Cruz Foundation (Fiocruz) has been selected in the first phase of the Unitaid call that aims to eliminate congenital transmisson of Chagas disease in endemic countries in Latin America. The goal of the initiative is to raise awareness on the disease and provide the much-necessary new diagnostic tools and therapeutic strategies, focusing on the reduction of mother-to-baby transmission, considered one of the...
Notícias
Data de publicação: 18/06/2020 - 15:52
Almost R$ 6 million (around US$1,2 million) in tests for Covid-19, personal protective equipment (PPE) and test devices will be donated to state of Amazonas to face the new coronavirus. The material will be transferred by the Oswaldo Cruz Foundation (Fiocruz) Program, United Against Covid-19. The distribution of products will be monitored by Leônidas & Maria Deane Institute (ILMD / Fiocruz Amazônia), explains the researcher...
Notícias
Data de publicação: 18/06/2020 - 15:22
The Institute of Drug Technology (Farmanguinhos/Fiocruz) concluded, in early June, the manufacture of Atazanavir pilot batches, an antiretroviral used to treat thousands of people living with HIV/AIDS. Public production was made possible by a technology transfer agreement from the American laboratory Bristol Myers Squibb to the Fiocruz unit through a Productive Development Partnership (PDP). The drug is used by thousands of people living...
Notícias
Data de publicação: 12/06/2020 - 11:57
The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be assessed in animal models. The synthetic form of the vaccine was chosen for being quicker than traditional methodologies, for its lower production costs, the stability of the...
Notícias
Data de publicação: 10/06/2020 - 13:19
During the new coronavirus epidemic, 36% of the Brazilian elderly who still work have been left without any income, or have experienced significant reduction in their income. Among those without a formal job, this number is even higher: 55%. These are some of the conclusions of ConVid - Behavior Survey, coordinated by Fiocruz, which has been attempting to investigate how the Covid-19 has been affected the lives of Brazilians. More than...
Notícias
Data de publicação: 09/06/2020 - 17:18
During the first weeks of social distancing due to the Covid-19 epidemic, a great part of the Brazilian population reported mood issues. Forty percent felt sad or depressed and 54% felt anxious or nervous frequently. The percentages were even higher among young adults (between 18 and 29 years old): 54 and 70%, respectively. This is one of the many results identified in the first phase of ConVid - Behavior Research, which aimed to...
Notícias
Data de publicação: 04/06/2020 - 13:47
In line with the history and spirit of Dr Oswaldo Cruz, the foundation that carries his name and celebrates its 120th anniversary continues to provide Brazil and the world with innovative and high-quality health services thus fulfilling the bold vision of its creator. In the pantheon of Brazilian national heroes in the field of science, Dr Oswaldo Cruz stands out as the most prominent figure. He was an ambitious man and knew exactly what he...
Notícias
Data de publicação: 03/06/2020 - 22:28
Health-BRC Biological Resource Center for Health and the Brazilian BRC Network Based on the experience with its microbiological collections, Fiocruz had dedicated e  orts to build the Biological Resource Center in Health (CRB-Health), which will consist of collections of pathogenic microorganisms, related mainly to tropical diseases or those with biotechnological potential in the health fi eld, including bacteria, fungi, protozoans, and...
Páginas Institucionais (antigas)
Data de publicação: 02/06/2020 - 13:50
They have as their primary function the acquisition, preservation, identification, cataloging and distribution of authenticated microorganisms to support scientific research, epidemiological studies, as well as the development and production of bioproducts for diagnostics, vaccine and drugs, and also acting as specialized services providers. For consulting the services provided by the microbiological collections, including their electronic...
Páginas Institucionais (antigas)
Data de publicação: 02/06/2020 - 12:18
Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology offers extensive coverage of the entire viral genoma, reducing errors that may occur in the process. In addition, it allows for the sequencing of the entire genoma of the pathogen directly from patient...
Notícias
Data de publicação: 02/06/2020 - 11:56
Created in 2009 based on an alliance between the Oswaldo Cruz Foundation (Fiocruz) and the Fórum de Comunidades Tradicionais de Angra dos Reis, Paraty e Ubatuba (FCT; Traditional Communities Forum of Angra dos Reis, Paraty and Ubatuba), the Observatory of Sustainable and Healthy Territories of the Bocaina (OTSS) has been considered by the Economic Commission for Latin America and the Caribbean (ECLAC) as “transforming...
Notícias
Data de publicação: 02/06/2020 - 09:40
João Aprígio Guerra de Almeida champions social mobilization to promote the use of donated breast milk for infants who cannot be breastfed directly by their mothers. The driving force behind the Rede Brasileira de Bancos de Leite Humano (Brazilian Network of Human Milk Banks), he is also the executive secretary of the Programa Ibero-Americano de Bancos de Leite Humano (Ibero-American Program of Human Milk Banks). In recognition of...
Notícias
Data de publicação: 01/06/2020 - 16:56
The Fiocruz against Covid-19 will benefit, all over the country, 145 projects that focus on vulnerable populations, such as quilombos (rural afro-brazilian settlements), indigenous peoples, riverside populations and favela dwellers. The initiative reaches more than 80 municipalities in all Brazilian states. The projects were selected through a Public Call for Support to Emergency Actions against Covid-19 in Vulnerable Populations...
Notícias
Data de publicação: 27/05/2020 - 11:58
In 2016, for the first time in Latin America, Brazil was the epicenter of a Public Health Emergency of International Concern. The unusual increase in babies born with microcephaly and other neurological disorders initially attracted the attention of bedside doctors in the Northeast; months later, the world looked at the country and its babies with concern. This was clearly a public health emergency, but it demanded a coordinated and...
Notícias
Data de publicação: 26/05/2020 - 14:34
Fiocruz celebrates its 120th anniversary this Monday, May 25. The date comes right when Brazil and the world are facing the biggest public health, economical, social, humanitarian and political challenge of the 21st century: the Covid-19 pandemic. The institution was founded with the name Instituto Soroterápico Federal [Federal Soroterapic Institute], with the purpose of fighting epidemics such as the bubonic plague, yellow fever, and...
Notícias
Data de publicação: 25/05/2020 - 18:37
More than 7.8 million Brazilians are at least four hours away from a town where high-complexity healthcare is available, such as an intensive care unit (ICU), suitable equipment and staff specialized in severe and acute respiratory diseases as the one caused by the Covid-19 epidemic. This is one of the main conclusions of the most recent analysis by the Institute of Scientific and Technological Communication and Information in Health (Icict), of...
Notícias
Data de publicação: 25/05/2020 - 15:41
In another step of its actions to combat the pandemic of the new coronavirus, the Oswaldo Cruz Foundation (Fiocruz) built in less than two months a hospital unit for severe patients infected by the disease. Located in Manguinhos, headquarters of the Foundation in Rio de Janeiro, the Hospital Center for Pandemic Covid-19 - National Institute of Infectious Diseases Evandro Chagas (INI / Fiocruz) started receiving, on May 19, the first patients....
Notícias
Data de publicação: 20/05/2020 - 16:57
The animation Carlos Chagas, which features the paths taken by the scientist until the discovery of Chagas disease, has just got a version in English. Available on the Internet, the episode is part of the series, Ciência em Gotas (Science in Drops), an initiative of the Casa de Oswaldo Cruz (COC/Fiocruz), which features the journey of Brazilian scientists with relevant activities in the field of public health and the environment. The...
Notícias
Data de publicação: 20/05/2020 - 16:28
The Institute of Drug Technology (Farmanguinhos/Fiocruz) has started the production of the first generic drug in the country to treat chronic liver infection caused by the hepatitis B virus (HBV). It is the Entecavir 0.5 mg, an antiviral drug that aims to reduce the risk of disease progression in patients and its complications, such as cirrhosis, liver cancer and even death. The production is the result of a cooperation with the Ezequiel...
Notícias

Pages

Back to the topBack